HOXC8 and neoplasm: The results showed faster tumor growth and heavier tumors in the overexpression group compared to the vector group, whereas the increased volume and could be counteracted by further treatment with an shRNA-lentiviral plasmid targeting HOXC8 (Fig .7c, d, e, f, Fig.S4a, b).